Population-based evaluation of second-line palliative chemotherapy (SCT) versus erlotinib (E) in advanced non-small cell lung cancer (NSCLC) patients (pts).
Krista Noonan
No relevant relationships to disclose
Cheryl Ho
Research Funding - Lilly; Roche
Sophie Sun
No relevant relationships to disclose
Barbara L. Melosky
No relevant relationships to disclose
Janessa J. Laskin
No relevant relationships to disclose
Nevin Murray
No relevant relationships to disclose